董洪梅｜暨南大学｜学者主页

期刊论文

2026

Interpretable MRI-Based Machine Learning Model for Noninvasive Prediction of Axillary Lymph Node Metastasis After Neoadjuvant Chemotherapy in Breast Cancer.

Xiaoyu Lai, Han He, Bo Liang, Zhi-Feng Xu, Lu Yang, Tingxi Wu, Kaiting Han, Weiling Li, Qing Liu, Cui-Ling Zhu, Ruijun Zhao, Geng-Xi Cai, Hongmei Dong, Yun-Jun Yang

Academic Radiology

DOI

2026

Circulating extracellular vesicle PTPRO methylation: an exploratory biomarker for minimally invasive diagnosis of early-stage lung adenocarcinoma

Hongmei Dong, Shuanglong Chen, Weiheng Cui, Pingshan Yang, Fan Liu, Song-Wang Cai, Hongzheng Ren, Shu-Yao Zhang, She-Gan Gao, Hao Zhang

Cancer Cell International

DOI

2026

Exosomal Non-Coding RNAs Orchestrate Immune-Metabolic Networks in Triple-Negative Breast Cancer

Hui-Xin Chen, Rong Luo, Jia-Kang Ma, Weiheng Cui, Hongzheng Ren, Shu-Yao Zhang, Yunlong Pan, Ruijun Zhao, W. Xiong, Hao Zhang, Hongmei Dong

Cancer Biome and Targeted Therapy

DOI

2025

Depletion of γ-glutamyl cyclotransferase suppresses the proliferation, migration and invasion of breast cancer cells accompanied by the activation of PI3K/AKT/mTOR pathway

De He, Weiheng Cui, Xijiao Pang, Jiale Dong, Quanwei Qiu, Hongmei Dong, Ruijun Zhao

Scientific Reports

DOI

2025

Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancer

Hongmei Dong, Ruijun Zhao, Weiheng Cui, Xijiao Pang, Hongzheng Ren, Yunlong Pan, Yexi Chen, Shegan Gao, Hao Zhang

Cancer Cell International

DOI

2024

A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast Cancer

Shuanglong Chen, Weiheng Cui, Jiale Dong, Wen-Yan Chen, Hongmei Dong, Ruijun Zhao

Journal of Cancer

DOI

2023

PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer

Ruijun Zhao, Shuanglong Chen, Weiheng Cui, Chaoyu Xie, Aiping Zhang, Li Yang, Hongmei Dong

Frontiers in Immunology

DOI

2023

PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET

Hongmei Dong, Wan‐Wan Lin, Liang Du, Zhimeng Yao, Feifei Li, Shuanglong Chen, Yiteng Huang, Hongzheng Ren, Yichen Luo, Songwang Cai, Yexi Chen, Hui Ru Tang, Xiaofu Qiu, Yunlong Pan, Xingxu Huang, Dianzheng Zhang, Dianzheng Zhang, Shegan Gao, Sai‐Ching J. Yeung, Hao Zhang

Cancer Letters

DOI

2022

PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer

Hongmei Dong, Chaoyu Xie, Zhimeng Yao, Ruijun Zhao, Yusheng Lin, Yichen Luo, Shuanglong Chen, Yanfang Qin, Yexi Chen, Hao Zhang

Frontiers in Immunology

DOI

2022

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

Hongmei Dong, Liang Du, Songwang Cai, Wan‐Wan Lin, Chaoying Chen, Matthew D. Still, Zhimeng Yao, Robert Paul Coppes, Yunlong Pan, Dianzheng Zhang, Shegan Gao, Hao Zhang

Frontiers in Pharmacology

DOI

2021

GAB1在ER阳性乳腺癌组织中的表达及其对MCF-7细胞转移能力的影响

张世民，董洪梅，赵瑞君

《西安交通大学学报(医学版)》

2021

Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells

Feiling Xie, Hongmei Dong, Hao Zhang

Frontiers in Immunology

DOI

2021

Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration

Hongmei Dong, Chaoyu Xie, Yuchen Jiang, Kai Li, Yusheng Lin, Xijiao Pang, Xiao Xiong, Jiehua Zheng, Xiurong Ke, Yexi Chen, Yong Li, Hao Zhang

Frontiers in Cell and Developmental Biology

DOI

2019

Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma

Yusheng Lin, Hongmei Dong, Weilun Deng, Wan‐Wan Lin, Kai Li, Xiao Xiong, Yi Zhuo Guo, Fuyou Zhou, Changchun Ma, Yuping Chen, Hongzheng Ren, Haijun Yang, Ningtao Dai, Lang Ma, Stephen J. Meltzer, Sai‐Ching J. Yeung, Hao Zhang

Clinical Cancer Research

DOI

2017

PTPRO通过去磷酸化和溶酶体降解机制抑制ERBB2阳性乳腺癌

董洪梅

《汕头大学》

2016

PTP1B在ER阳性乳腺癌中的表达及临床预后意义

赵瑞君，谢春伟，陈戈，龚宇，董洪梅

《临床与实验病理学杂志》

会议论文

2017

Androgen receptor forms a regulatory circuit with IL-6 to control esophageal carcinogenesis

董洪梅，甘进锋，杜亮，张灏

《2017年中国肿瘤标志物学术大会暨第十一届肿瘤标志物青年科学家论坛论文汇编》

DOI

2017

Membrane tyrosine phosphatase PTPRO represses ERBB2-induced breast oncogenesis by dephosphorylation and degradation of ERBB2

董洪梅，甘进锋，姚志猛，张灏

《2017年中国肿瘤标志物学术大会暨第十一届肿瘤标志物青年科学家论坛论文汇编》

DOI

2017

Targeting growth hormone-releasing hormone receptor by peptide analogs inhibit human gastric cancer

Jinfeng Gan, Xiurong Ke, Hongmei Dong, Zhimeng Yao, Hao Zhang

《2017年中国肿瘤标志物学术大会暨第十一届肿瘤标志物青年科学家论坛论文汇编》

DOI

预印本

2023

PRMT5 Promotes Esophageal Carcinoma Metastasis by Enhancing PAK1 Phosphorylation

Guowu Wu, Xiaofang Zou, Yi‐Wen Lin, Yuhua Meng, Shuanglong Chen, Yinfang Gu, Longhua Guo, Lilan Yi, Hongmei Dong, Lu Wang, Dianzheng Zhang, Hao Zhang

Research Square

DOI

董洪梅

精选作品

期刊论文

Interpretable MRI-Based Machine Learning Model for Noninvasive Prediction of Axillary Lymph Node Metastasis After Neoadjuvant Chemotherapy in Breast Cancer.

Circulating extracellular vesicle PTPRO methylation: an exploratory biomarker for minimally invasive diagnosis of early-stage lung adenocarcinoma

Exosomal Non-Coding RNAs Orchestrate Immune-Metabolic Networks in Triple-Negative Breast Cancer

Depletion of γ-glutamyl cyclotransferase suppresses the proliferation, migration and invasion of breast cancer cells accompanied by the activation of PI3K/AKT/mTOR pathway

Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancer

A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast Cancer

PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer

PTPRO suppresses lymph node metastasis of esophageal carcinoma by dephosphorylating MET

PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

GAB1在ER阳性乳腺癌组织中的表达及其对MCF-7细胞转移能力的影响

Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells

Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration

Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma

PTPRO通过去磷酸化和溶酶体降解机制抑制ERBB2阳性乳腺癌

PTP1B在ER阳性乳腺癌中的表达及临床预后意义

会议论文

Androgen receptor forms a regulatory circuit with IL-6 to control esophageal carcinogenesis

Membrane tyrosine phosphatase PTPRO represses ERBB2-induced breast oncogenesis by dephosphorylation and degradation of ERBB2

Targeting growth hormone-releasing hormone receptor by peptide analogs inhibit human gastric cancer

预印本

PRMT5 Promotes Esophageal Carcinoma Metastasis by Enhancing PAK1 Phosphorylation

研究方向